Nuwellis Inc (NUWE)
How it compares with the broader market is one of its lowest-scoring factors; price trend score is near the bottom of its range; company finances score is below the middle.
NUWE scores higher than 12% of the 1,101 tickers we compare it with (Health Care).
As of 10 October 2026, Nuwellis Inc (NUWE) scores 21 out of 100 on the Market Census six-factor composite, which puts it at the Low score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 10 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.07× 30-day average
- 52-week range
- 0.67 – 172.90
- Market cap
- $3.27M
- Earnings date
- 10 Nov 2026
- Volume
- 153,915
- Avg. volume (30d)
- 2,290,452
- Open
- 0.70
- Previous close
- 0.68
- Day's range (regular session)
- 0.67 – 0.71
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 0.08
- P/E (TTM)
- —
- EPS (TTM)
- -136.17
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
What the score says about NUWE right now
Nuwellis Inc (NUWE) currently scores 21/100 on the Market Census six-factor composite, at the Low score level. NUWE is +2.06% on the day and -0.69% over five sessions as of the most recent tick. Low is the lowest level. Much of NUWE's data reads poorly right now. Market Census does not tell you to short it; the level only describes the data. NUWE's strongest factor is market mood at 50/100 — a fairly good read on the overall market. The market mood is the same for every ticker at a given moment, so it says nothing about NUWE itself. The weakest factor is strength vs the market at 0/100 — well below average next to the wider market.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See NUWE in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent NUWE news
Latest headlines that name Nuwellis, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT SystemYahoo
- Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical ConferencesYahoo
- Nuwellis To Participate In Four Medical Conference This Month To Present Data, Discuss Role Of Its Aquadex SmartFlow SystemBenzinga
- Nuwellis Reports 31 Aquadex Console Sales in 2026, Expanding Recurring Revenue OpportunityYahoo
- Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue OpportunityYahoo
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to NUWE’s 21, all within 1 point.
Sorted by closeness to NUWE’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.